Join to View Full Profile
9200 Pinecroft Dr Ste 450Shenandoah, TX 77380
Phone+1 281-296-0365
Fax+1 281-298-8907
Dr. Ryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 2000- Duke University HospitalResidency, Internal Medicine, 1994 - 1997
University of Rochester School of Medicine and DentistryClass of 1994
Certifications & Licensure
TX State Medical License 2014 - 2027
PA State Medical License 2010 - 2014
MA State Medical License 2000 - 2010
NC State Medical License 1996 - 2001
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2015-2017
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2015-2017
Clinical Trials
- Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer Start of enrollment: 2007 Sep 01
Publications & Presentations
PubMed
- 7 citationsA randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.Erica L Mayer, Nabihah Tayob, Siyang Ren, Jennifer J Savoie, David R Spigel
Breast Cancer Research and Treatment. 2024-02-01 - 14 citationsReal world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community...Gregory L Price, Lavanya Sudharshan, Paula Ryan, Jonathan Rajkumar, Kristin M Sheffield
Current Medical Research and Opinion. 2022-08-01 - 48 citationsOverexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple negative breast and serous ovarian cancersNicolai Juul Birkbak, Yi Li, Shailja Pathania, April Greene-Colozzi, Matija Dreze
Annals of Oncology. 2018-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
